The Spiralling Cost of Dementia: $800bn and Counting
News Mar 31, 2017 | Original Story from the University of South Florida
More Americans are living longer and surviving chronic conditions like heart disease and cancer. Ironically, this triumph is also leading to a drastic rise in neurological disorders, which disproportionately attack the elderly.
Clifton Gooch, MD, professor and chair of the Department of Neurology at the University of South Florida Morsani College of Medicine in Tampa, is the lead author of study that details the enormous cost of neurological diseases to the nation. The study is reported in the Annals of Neurology, the official journal of the American Neurological Association and the Child Neurology Society.
Working with USF College of Public Health colleagues Etienne Pracht, PhD, and Amy Borenstein, PhD, Dr. Gooch looked at the nine most prevalent and costly diagnosed neurological disorders and found the annual cost is staggering, totaling nearly $800 billion. By 2030, $600 billion will be spent treating stroke and dementia alone. In addition, low back pain, traumatic brain injury, migraine headache, epilepsy, multiple sclerosis, spinal cord injury and Parkinson’s disease emerged as the most common disorders posing a serious financial burden.
“Given these extraordinary and rapidly growing costs, a concrete strategy is urgently needed to reduce the burden of neurological disease,” he said.
In the paper, Dr. Gooch calls on the federal government to provide more NIH funding to speed the development of treatments and cures for diseases such as dementia and stroke, including therapies to delay, minimize and prevent them. He also proposes the creation of a more effective national database to track treatment successes and failures.
“The very future of the neurological sciences and the patients we serve is now at stake, and the welfare of generations yet to come hangs upon the success of our efforts.”
Dr. Gooch writes that the years of productivity lost in the 100 million Americans living with neurological and musculoskeletal disorders is more than any other category of disease.
This article has been republished from materials provided by The University of South Florida. Note: material may have been edited for length and content. For further information, please contact the cited source.
Comments | 0 ADD COMMENT
Global Neuropharmacology and Neurochemistry Congress 2017
Oct 02 - Oct 04, 2017